Dutch medtech startup Xeltis secures €15 million to develop pioneering medical treatments

Published on August 10, 2022

Xeltis, a Dutch medtech startup, has secured €15 million of fresh investment from Chinese firm, Grand Pharma. The startup is developing medical devices to treat cardiovascular disease and as a result, aims to lessen the incidence of CKD. Chronic Kidney Disease (CKD) is reported to affect 9% of the population – and its prevalence is…

This content is for members only. Visit the site and log in/register to read.

The post Dutch medtech startup Xeltis secures €15 million to develop pioneering medical treatments appeared first on EU-Startups.

Continue reading on website
Other news

Are 3M, Honeywell, GE Buys After Quarterly Reports?

August 10, 2022
Industrials 3M, Honeywell and General Electric are all trading higher following recent earnings reports. The broader sector is also rallying in the past month.

South Africa’s DataProphet closes $10M to scale its AI-as-a-service platform for manufacturers

August 10, 2022
Manufacturing plants or factories take raw material inputs and add value through a sequence of unit processes before shipping a product. Now, this process must follow a recipe. There are a series of instructions for products such as cars; in those instructions, a list of parameter values, specific temperature for iron melting, specific pressure for mold casting… and the list goes on.These factorie